Canadian Securities ExchangeThe Daily Bell

Going Public in Canada - Brazil Edition

Presented by the CSE and MZ Group

April 12, 2022Special Presentations

About This Video

The CSE, in partnership with MZ Group, is proud to bring you Going Public in Canada, a one-hour virtual event that took place on April 5, 2022.

Learn about the ins and outs of going public in Canada. Moderated by Anil Mall, Director, Listed Company Services at the CSE, the event features industry experts Corey Giasson, President, CEO & Director of MustGrow Biologics (CSE:MGRO) and Peter Simeon, Partner at Gowling WLG. During this fascinating panel, we discuss the reasons a company may want to list in Canada, and examine successful case studies and the listing process with a law professional.

Gain insightful takeaways as we discuss:

- Why choose Canada to go public? What are the advantages?

- Expansion of shareholder base and diversification of shareholders

- Connecting with new opportunities

- Additional sources of capital and funding

Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe

STAY CONNECTED WITH THE CSE

=============================

- NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe

- PODCAST: https://blog.thecse.com/cse-podcasts/

- INSTAGRAM: https://www.instagram.com/canadianexchange/

- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange

- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/

- TWITTER: https://twitter.com/CSE_News

- BLOG: https://blog.thecse.com/

- WEBSITE: https://thecse.com/

- MAGAZINE: https://issuu.com/thecse/docs

Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.

noon evening whatever time it is in your time zone for this special presentation brought to you by the canadian securities exchange we'll be talking about going public in canada and what that entails i want to start off by thanking amanda munoz and her team at mz group for helping us put this together and making sure we've got a room to present to i'm a neil mall i represent the

canadian securities exchange i'm based out of here in vancouver and i'm the director of listed company services joining myself today will be peter simeon peter is a partner at gowling's llp which is a law firm as well as corey jayasan corey is the president ceo of moscow biologics and gents thank you so much for taking the time to join us today for this presentation what we'll do is i will start off

with a presentation on the canadian securities exchange what the exchange is about we'll go over some of the details that and then we'll have a small presentation from peter a small presentation from corey we'll go through some q and a's about going public in canada and then we'll open up the room to the audience we do encourage you if you have any questions feel free and type them out in

the chat box or in the q a section and we'll do our best to go ahead and answer these questions our presentations will also be available for download via the link and we'll obviously send them off later on but if you have any questions and you don't want to jump on on on stream and ask us feel free to reach out to either of us at your own

convenience we're more than happy to take your phone calls or emails and talk to you about what that process looks like so without making everybody wait a little bit longer what i'm going to do is i'm going to go ahead and present what the cse is all about so i'm going to go to the next slide here so why canada why would companies choose to list in canada well we have an access

to an ecosystem that's oriented to early stage public venture capital canada is also home to the most public companies per capita in the world and it's a platform into the us capital and trading markets we'll go to the next slide please just going to go over a quick primer about the csc we were founded in 2003 and now are well into our second decade of operation our national presence is

with our headquarters which is based in toronto ontario you'll see a picture of our building on this slide our mission at the cse is to provide a modern disclosure-driven exchange model to facilitate cost-efficient capital formation for public issuers cse has been the world's fastest growing small cap stock exchange for tech cannabis resource novel industries as well as emerging markets in the last little while we have raised over

eight billion dollars in capital we've got over 771 listed companies and the exchange market cap of 43.3 billion dollars next slide please i'm going to go over a few reasons five reasons to list on the csc reason number one would be to collaborate with an exchange that places the entrepreneurs experience at the center of their business model access to public capital with no sector limitations is another reason

as well as experience time and cost savings as a result of csc's efficient listing model you benefit from a global liquidity profile on an established exchange and companies can also leverage csc's digital network as well as our global reputation to gain investor attention and further leverage your corporate listing next slide please so in in 2020 2021 we listed 182 new companies i'm just going to go through

this quickly we had about 68 in the resource sector which is mining oil and gas etc we had 51 in the tech space and out of that seven were clean tech focused companies 24 in the cannabis space 16 companies listed in the life sciences out of that 11 were psychedelic focus companies we have 22 companies listed in the diversified sector and about 12 of those were in the

plant-based food space we had about 27 ipos in 2021. we'll talk a little bit about our regulatory framework so the csc has two principal regulators one is the osc which is the ontario securities commission and the bcsc which is the bc british columbia securities commission they work in harmony with the amf and all other provincial securities regulators and as with all of the canadian exchanges national instruments

such as the 43-101 apply to all cse listed companies timely disclosure policies are all administrated by iraq and the csc is a designated stock exchange by the department of finance in canada we are subject to iraq monitored trading and a regulation as sec designated offshore securities market in the united states our companies have access to data and trading so the csc is fully integrated with professional trading and market

information networks in canada these include key vendors such as bloomberg reuters which is refinative s p global iris morningstar and and more familiar names like google finance and yahoo finance trading is available across all discount trading platforms in canada these include wealthsimple desjardin online investor line national bank direct brokerage cibc investor edge q trade quest trade and a lot more cse listed securities are rrsp and tfsa which is a tax-free

savings account eligible in canada they are also eligible for sips in the uk and iras in the united states level two trading data is available you can log go to our website which is the cse.com or you can reach out to myself after this presentation u.s and international access which is probably a topic that you're all very curious about the csc is recognized

qualified for an exchange in the us by the otc markets group with over 200 cse listed securities trading on the otc qb and the otcqx markets growing direct across sorry growing direct access to the exchange from the u.s and internationally through interactive brokers which is mainly for the large issuers and other institutional and retail oriented brokers in u.s as well as europe there are companies interlisted with nasdaq the aqueous exchange in uk the

lse and frankfurt boris so very quick primer on the csc so i'm sure if you have more questions like i mentioned i'm the director of listed company services based here in vancouver you can feel free and reach out to us at your convenience and we're more than happy to take your calls or emails also we've got a good presence across all social media channels you'll see on

the screen here feel free and you know obviously take a look at our youtube channel which is csctv and follow us on other social media channels to keep up with some of our events that's the presentation from the canadian securities exchange i don't want to take up too much time here but what i'm going to do is i'm going to actually pass the virtual microphone over to peter

simeon and as i mentioned earlier peter is a partner with gowling's llp peter it's all you thanks emil you know we do lots of transactions with the csc we've listed you know probably hundreds of companies there it's a great exchange i'm very business focused very commercial practical we love working with the cse as anil said i'm a partner at gallings i've been practicing about 20 years focusing

on you know corporate finance and capital markets i take companies public i list them on stock exchanges we do a lot of public and private m a where clients are buying you know companies are selling companies also i do a lot of financing workforce and capital for clients either when they're private or after they're public a little bit about galling so gallon wg is a large international law firm

we have offices all across canada we have offices in europe and in asia we're fairly industry focused at our law firm and you know we have a lot of different practice areas you know other than what i do you know we're known for our ip group our litigation group as well as the corporate group which is what i do i'm gonna be talking about going public in canada just keep the presentation

quick you know keep it high level and then we can get in some questions next slide so there are there are three main methods of going public in canada the first is an ipo or initial public offering and this involves filing a long-form prospectus the second is our reverse takeover of a shell company and the third is a direct listing by way of non-offerings and i'm going to just walk through each

of these three ways next slide so an ipo issuers need to prepare preliminary prospectus which gets reviewed by the canadian securities regulators and the stock exchanges although the exchanges tend to rely on the regulators when you're doing a prospectus versus you know when you do an rto and you're doing a listing statement the prospectus needs to include full true and plain disclosure of all material facts relating to the

securities offered in the company usually you file the the preliminary prospects you get comments back from the regulators you address those comments and then you file you know a final prospectus there's always an underwriter that's involved and they you know market and sell the securities they will do full sort of diligence on the company you'll have auditors involved they'll do financial statements and sign audit opinions so it's a fairly long

process you know so the waiting period is sort in between when you file your preliminary after you get your final people typically are are marketing in that period and raising the funds you then get a final prospectus and you can proceed then to close your ipl list on the stock exchange it is a lengthy process like most you know ipos will take you know at least six months

in my opinion something a year you know preparing financial statements is a time consuming process you need that for any of these ways of going public but just the scrutiny on a prospectus i think is a bit more so from a diligence perspective because it has to have sort of fultrum claim disclosure next slide a reverse takeover so this is when a shell company and there's no real shell companies on the csc but

they're you know i think companies that have limited operations or failed businesses and they will acquire a private company you will need shareholder approval of you know of that shell company to do that rto transaction the the shares usually get halted in that period where you announce the deal before closing there's no prospectus that the securities regulators don't review you know the listing statement or the filing statement the stock

exchange does but the stock exchange will provide you know their comments on on the disclosure document we'll have to address those the statements also have the you know the listing statement has to contain full trump disclosure and if you do have a financing or agent involved you will have diligence there as well you know on other exchanges we'll sort of remain nameless for this presentation but there

are other ways of doing it you know some cpcs g-corps stocks etc but at rto reverse takeover is the most popular method of going public in canada it's sort of the way most people choose to go public next slide so so the last way is a direct listing and this this way is you know is a bit different than an ipo i mean that there's no real underwriter or agent

involved but you are filing a prospectus but it's a non-offering perspective so the regulators will review that they'll comment on it but typically it's i think less of a review and a timeline that if you're filing an offering prospectus you're actually offering securities under the prospectus you need to sort of you know the sort of drawback here is that there's no distribution when you do an r2 with a

shell the shell company will have you know at least 150 to 200 shareholders needed to meet minimum listing requirements on a stock exchange when you do direct listing you don't have that so you'll have to make sure you sort of build that into your cap structure in advance but the benefits are they are sort of less costly less timely more efficient than a traditional ipo and you don't give up the dilution you

would give up on an rto where you have to give you know the shell a piece of that sort of resulting issue so we are seeing a lot of clients do a direct listing as well they want to save that dilution next slide so as i said so the most common method of going public in canada through an rto this is you know how most companies get get listed and

you know you acquire all the securities that private entity and then you'll list that resulting issuer interestingly enough you know the csc was one of the only stock exchanges early on was frankly the only stock exchange that allowed for canvas companies to to get listed in canada that was one differentiation feature you know as in you know we're talking a lot of brazilian companies there's an

emerging markets type country if you you know if you have sort of other issues you want to address those early it sometimes takes longer to clear piffs or have background checks done for emerging markets and again sometimes describing sort of foreign companies and dealing with either sometimes opinions or other things are needed you want to get in front of that early so that's something to think about

next slide it's just sort of so i'll finish with sort of you know not to the general description but more than advantage disadvantage to each of the three types because i've already described them so on an ipo the advantage is you will have a big splashy type you know going out party with an ipo it gets in front of the most amount of people it attracts a lot of retail investors

you get the most amount of attention generally the disadvantages are like you will you know you will have it take a lot more longer it'll be a lot more scrutiny it'll cost a lot more money than other ways of going public but obviously you know an ipo is still an ipo and people that want a you know splashy sort of transaction have a larger market cap we'll choose to do

that an rto is as i said the most common way of doing it it's shorter you can do it in as quick as three months you know sort of four or five months usually the diligence tends to be a bit simpler than it would be on an ipo the disadvantages are you're typically sort of raising capital through a secondary or private placement or sub-receipt transaction that's not under

the prospectus you will have to pay something for the shell so as i said you're sort of diluting your company a bit you know shells are going for you know 750 to a million dollars plus cash so it's actually a fair bit of dilution depending on how large your company is and then you're inheriting sort of the the shell right so you're getting sort of warts and also you like to say all of

its you know prior history it's liabilities et cetera are going to come through in transaction versus just your company and so then the direct listing is kind of you know a little bit of both right it is from an advantage side it is a little bit easier that you're not doing a full-blown ipo you're sort of dealing with just describing your company and my comments on that

and you will not have that dilution which i said before which is great but on the disadvantages you know you are dealing with a stock you're not just dealing with stock exchange you're dealing with the securities regulators they will review your prospectus and you will need to you know you will need to find that additional you know amount of board lots and shareholders i said before

so like you know next slide that's sort of it on my presentation those are the three main ways of going public you know sort of pros and cons of each and we see different clients depending on their business needs choose one another although i still think in rto is the most popular although we are seeing more direct listings in the last couple years we've seen you know before

that thank you peter we'll we'll move on next to corey jason corey is the president ceo of muscular biologics corp which trades on the csc under the symbol mgro corey all you yeah thank you very much it's a pleasure to be here today i'm we're an a biotech company based in canada we've been public on the cse since july 2019

and our method of going public was the direct listing version and it's been great so we'll get right into our presentation i'll tell you a little bit about muscular and some of the reasons why we did go public so if we flip over to slide number two the disclaimer your typical forward-looking disclaimer you know i'm gonna be making forward-looking statements here and it can be read in

detail on our website at musco.ca go to the next slide about our company so we're a biotech company a pre-revenue company with a natural organic technology platform that is highly efficient at controlling diseases pests and weeds we have a natural way to help farmers grow crops it's a sustainable innovation with the potential to replace synthetic chemicals it's a plant-based i know mentioned there are some plant-based

companies on the csc i didn't realize that ours is plant-based not not to eat necessarily it's dried from food-grade mustard but it's more for use of the compounds within to help protect these crops so that they can grow it's sustainable positive soil health and ecological impact which is very important in the market today it's one of the reasons why we are public we feel that our technology is

got a great fit for the market and investors are interested in this type of technology i mentioned we went public in july 2019 but for probably about nine years prior to that there was a lot of work done on this technology a lot of money spent i i estimate about nine million dollars canadian over 110 independent studies that showed that the technology was very efficacious at controlling the diseases and pests

but the issue was back in about 2015 time frame the company ran out of money so we had to find a new way to to raise money and that was going through the public realm and you can see there we've got a very tight capital structure 42 or sorry 49 million shares outstanding 55 fully diluted that's that's very important to us and we're fortunate to be sitting on 9.3

million dollars of cash on hand that is a you know significant amount of money for a an early stage company like ourselves and that doesn't include the money that our global partners are now starting to spend we've got partnerships with sumotomo bayer and nexus bioag which i'll get into here shortly the key market drivers here are agriculture you know we're helping farmers grow crops they're gonna need

you know there's we're gonna need more and more food with a growing population and there's a finite amount of arable land and now with some synthetic chemicals being banned farmers are missing a tool that they've used in the past to help protect these crops and that's what we're bringing to the market we're helping to provide that solution it's a very innovative technology it's very unique we're basically

extracting what you know nature's provided the mustard plant and providing in a commercial form and we feel that this this story here fits very well in the public realm as i mentioned our technology is very unique so compared to synthetic chemicals it is it is just as effective but it is also safe we're derived from food grade mustard you eat it when we have wasabi up here in canada it's actually

dry it's crushed mustard seed and food coloring so the active compounds are being released in our mouth whether we know it or not but compared to biolog biologics other biological products out there on the market which are safe the efficacy hasn't been met with them and what we're seeing is that we're kind of unique in a sense that we are safe or natural we're organic but you know we have the efficacy of

synthetic chemicals and and that's really key that's what we're bringing to the market and you know some of the news announcements that we've provided over the last few years being a public corporation that's drawn a lot of attention to to our company you know we've had success in say bananas in in colombia or in you know canola up here in canada you know so we've provided we've been

able to partner with some key egg players which is very important it's allowed us to go global bayer was our recent announcement we're partnered with them in europe asia the middle east and africa and that is to do field development work and help push our technology forward to commercialization with sumotomo we're partnered in the americas and nexus biowa we're partnered with them on two important canadian crops

canola and pulses but in any event we've taken a small team made it a lot bigger we have a lot more expertise on the r d side on the regulatory side and pushing our technology through to commercialization so we've got some excellent partnerships and i believe part of this came through being a public company and making our company more aware in the public in the

public markets when we originally started our the restructure here and taking the company public back in july 2019 we were really focused on the top part of this technology platform focused on fruit and veggies specifically in the us and that's where we're currently working on getting our registration right now but since then you know we've raised a significant amount of capital that's allowed us to

expand our technology pipeline and do testing in more areas we've done testing in bananas in colombia on fezerium wilt tr4 we're testing canola and pulse crops here in canada on too hard to kill diseases a club root in aphenomyces we've come up with another extract a bioherbicide extract called thiocyanate that potentially could be used as a non-selective herbicide and we're now going to be focusing in even more on the post-harvest side

food preservation side you know for stored potatoes bulk grains etc etc so our company's gone from i believe when we when we originally did the ipo we were about a seven to ten million dollar canadian market cap to almost 200 million dollar market cap agriculture's a a big sandbox we're talking about multiple billions of dollars of fema gate or chemical

sales annually in in in these areas so we're excited to be in the sustainable agriculture space here right now this is a snapshot our last slide sorry i should have mentioned on slide number eight this is a snapshot of our capital structure you know over the last year you can see we've had a pretty good momentum being an agriculture sustainable agriculture company we've got a very tired

capital structure which we feel is very important average volume on the csc over the last three months is 65 000 shares per day that's come off slightly but there's also been a you know you know come off a slight downturn in the technology space and that so you know and again the key for us is the cash position 9.3 million dollars we wouldn't have been able to raise that

money as a private company and that's why we went to public so thank you very much for allowing us to present

thank you very much corey so you've you've now heard the three presentations obviously the canadian securities press up securities exchange presentation the presentation from peter simeon talking about gowlings and their role within this ecosystem and then corey jason from muscular biologics talking about the angle and viewpoint of a public company that's actually listed in trading so we're gonna move on now to sort of some questions that we'll

we'll be talking about based on some of the points that both peter and corey have already touched on so we'll dive into him a little bit more but to our viewers if you do have any questions if you're curious about something feel free and jump in with your your comments or questions because we can take them at the same time as well i think that will

make for a much engaging a a better discussion that we're having now obviously we've all touched on this topic of going public when it comes to entrepreneurs and early stage companies everybody has individual requirements on why they choose to go public so peter do you mind maybe touching in on some of the strategies that are taken or or or let's say why an entrepreneur and a company

would choose to go the public realm yeah i think there are two main reasons you see why people choose to go public one is corey set his access to council it's a lot easier to raise money as a public company or if you've got a plan to go public you know a lot of people don't want to just invest in private companies and then two is just liquidity for

for shareholders a lot of times shareholders that come in early on at some point want some liquidity and it's you know it's tough for them to sort of sit in a private company for too long they want some exit at some point those are the two main reasons yeah corey do you have anything to add to that yeah those were the two main reasons for us but i'd also add you know to help

get exposure and to get your story out there and that as i mentioned we've got partners now and you know that i think that was able to come about because we're announcing making announcements in the in their industries in that so i think i think you touched on a great point there story because you know it's very important to be able to meet those milestones and build shareholder

confidence and then you know creating awareness for your story because no matter how good your product or company is if the general street or capital markets do not know about it it's very hard to then gain traction while you're out there trying to raise capital exactly now you know obviously peter you touched on this earlier there are several advantages and disadvantages to listing and going public

you know future raises is one of them which is an advantage because you have more access to raising capital you have improved public awareness which corey you touched on let's talk a little bit about you know a public company being then able to acquire talented staff and getting out there do any of you have to have anything to add to that corey maybe you can touch on this one

because i i i we're running pretty lean there's not very many of us so we we're actually leveraging our partners know-how and expertise and that and that's i think really key so i really don't have any expertise in that in that area so what about acquisitions being able to then go out there and acquire more and do some m as and stuff like that yeah i mean we haven't

focused on that ourselves to date but i mean obviously to be able to do those acquisitions you know you need to either have capital or you need to be able to issue issue shares to to be able to do those types of deals and all that and it's a lot easier to do that as a public company and for sure and i know we've touched on the

advantages but it's only fair if we talk a little bit about the disadvantages as well that individuals and companies will come across when they go through that listing and becoming a publicly traded company obviously peter you touched on this earlier in your presentation that there's increased scrutiny there's a lot more you know regulations and and disclosure that you have to follow you want to maybe talk a

little bit more about that yeah i don't think a lot of people going into the process understand the amount of work it takes to get public and frankly you're you know as a ceo or cfo you're going to focus so much your attention on the going public process the disclosure documents that you want to make sure someone else in the company's running the business like i've seen a lot of clients sort of lose track

of their business a bit as they're going through this process because it's hard to focus on both at the same time and just getting in front of some things like an audit takes a lot longer than you think it's one of the first things i ask clients when they say they're ready to go public like you have audit financial statements because it takes a lot longer than you think

i think i think that's one of the most important things like you mentioned peter because it's almost a secondary thought at times but in order to move forward to get a public listing that is the most important step that you need to have in order is your your your audits now there's obviously regulatory oversight that you have to worry about there's a little bit of reduced management control also that comes when

you didn't decide to go ahead and list you want to maybe touch on that yeah well you know when you're a public company you obviously have a board of directors there's independence requirements for that board for the audit committee under stock exchanges so you will have more oversight on management it's not sort of one entrepreneur with you know either shareholders that are tightly bound to shareholders or agreement or other

things and you know shareholders that can buy stock in the market they could they have a big enough position requisition meetings and things like you have to actually be a little more accountable to your shareholder base as a public company and you've got more fiduciary obligations like the board and management reduce your obligations their shareholders you have to think about what's in the best interests of the company in your shareholders which is

different when you're just one one or two people at other private companies right yeah now obviously there's equity dilution when you're going out there and raising capital those are all things that you know individuals and entrepreneurs should definitely pay attention to before they go through that process of listening you know not all not every time is it right for you to go public it's all about timing now let's talk a little bit about timing

corey i'm gonna i'm gonna jump at you for this one so going through the process and listing musculo and going public what are some of the key factors when it comes to timing and having the right timing well it's a great question i wish i knew i think it's more luck than anything you know we have a technology that we believe in and we think that it needs to

be commercialized for the the betterment of mankind you know we need to be able to grow food sustainably it's good for the soil it's good for people it's good for workers it's good for people that eat food so we believe in it we know it works we need capital we need help to go and get it there and just so it just so happens that we hit good timing

sustainable agriculture is becoming more and more important and it's a forefront right now and i believe it's not going away because you know what i'm gonna go eat tonight and i'll eat tomorrow too it's so it in terms of the timing thing we got lucky and that but it's an important factor for sure you know i want to talk to you while we while we have you up here let's

talk about your experience what was it like for you and your team as you were going through that listing process was it an easy sort of turnover or were there hurdles that you and your team had to jump through that you might not have been aware of before you begin that began that process you know i think we we have good advisors around us we've got a you know a good legal counsel

that's been there done that you know same with on the audit side my cfo todd lottie he's been involved in ipos on the nasdaq in the past so we've got a lot of good expertise in house i mean i it's never going to happen as quickly as you want and that that that was for sure but you know it it's important to have a good good

surrounding cast to help get there and and i i agree with the it does take up more of your time as a ceo and you have less time focusing on operations so it's important to have help around you so that you you don't drop the ball in operations and all that kind of stuff you you said it well corey having the right team and the right people surrounding you as you go through

this process is very important peter do you have anything to add to that i'm sure you do yeah it always takes longer than you think like it'll always take longer it'll be more work than you think and sometimes some things are out of your control for instance you're trying to raise capital sometimes there's a market window that opens and sometimes it closes and sometimes you know your underwriters or bankers will tell you

like today's not the day to go public and raise company wait six months wait three months like a lot of it is luck as corey said it's sort of catching a window and getting public in that window so just prepare enough in advance and then when the the timing is right you can strike right now i wanna i wanna actually jump into the topic of ipo versus rto i know

both of you touched on this a little bit peter you mentioned that in your presentation you know quite a few companies will choose to go that rto round to have a shorter time to then list and and begin trading corey you mentioned that muscle decided to go the direct listing route can you maybe talk to us about your strategy behind going and doing a direct listing

yeah well i think a lot of it has to do with risk and that we you know we wanted to be successful and we didn't want you you know our technology probably at the time wasn't that well known or you know maybe not at the forefront that you know being a sustainable agriculture company technology company whereas if we were maybe facebook that would be a totally different situation

than that you're hitting it at the you know and peter you can talk about this better than i can but to me it was a you know risk reward and what we've seen is the direct listing was the least risky route for us yeah i agree unless unless you're you know a really large company with you know like a billion dollar diet market cap like an ipo doesn't tend to make

sense from a cost perspective it's it gets very costly and you don't really need it to access the capital markets in canada and most people when you tell them you're doing an rto like they understand what that means that's how most companies get public in canada so you know will we do some ipos yes and last year you know there were sort of a slew of tech ipos is about unusual

but traditionally you're doing more rtos and that's the way people tend to go public so unless you really want that big flashy you know ipo unless you're facebook or a really large company you know most clients we advise either the rt or the direct list peter you touched on this earlier in your presentation as well about being very careful when you are doing the rto route and using a shell let's talk about

some of the hurdles that companies can and sometimes have come across when using a shell yeah a lot of times there's liabilities you don't know about like you got to do your diligence you got to go look at their financial statements like what live bills are out there you know deal with any creditors like i've never seen a going public transaction that you know someone didn't put their hand up at some

point looking for something right so you're going to find some stragglers on an arch to other you know either from the past so they're looking for you know some cash because there's money on the table all of a sudden so you want to do your diligence and make sure you can minimize that but there'll always be some element of that to be honest there's there's always you you're very

right about that and and again you know you have to remember you're you're dealing with past shareholders of a company that's no longer active and these shareholders might just be looking for an easy way out so here you are as you're building momentum for your brand new listing you're almost swimming against the tide where and have shareholders that might be working against you while you're you know trying to

get more awareness and and momentum during the first couple of weeks of trading that's a very important point to bring up as well now cory i want to talk a little bit about you know obviously your company moscow has been listed since 2019 i think you mentioned july of 2019. so you've had now a a good amount of time in the public market so maybe can you talk to

the audience about what your and your team's experience has been like as a company that's navigating the public markets and then as a company that's listed on the csc how's that experience yeah i mean it's been it's been it's been great to tell you the truth you know you're always kind of worried about it in a sense i mean being a technology company you know we we also have to be careful

about the information that we're putting out there we're pretty revenue we don't have you know you want to update the shareholders on certain things but you know there's certain things that we can't be discussing or updating in that so you gotta you know the difference between that and a private company is we've noticed that that's you know some things that we have to hold the cards

close to us for certain stuff say patents applications or what have you you know and i think the cse has been a it's been a really good place for us to to to list i think you guys hit it you know the nail right on the head there at the beginning as you know we're entrepreneurs we don't want to get bogged down with

regulatory and you know stuff like that and in terms of being a public we want to be public we want our shareholders to have access to liquidity and be able to trade their shares but but you know we wanna we create value by focusing on our technology and taking that of course commercialization and as entrepreneurs i believe the csc has really allowed us to do that

well said corey peter i'm not sure if you have anything to add to that but you know from it from a public company point of view but i'm sure you've got clients that you've brought on board to the csc i'm sure they give you feedback what's that been like the sentiment of being a company listed on the csc yeah yeah all my clients have nothing but positive

things to say like the csc is an entrepreneurial type of exchange it's very practicable and commercially driven you can always pick up the phone i do it all the time i'll call you know mark or rob and you know in their listening group and just ask them questions hey i looked at your rules you know the client they're looking at doing this how can we get through it how do we structure it

like they're very open to having those discussions and trying to create you know solutions not not sort of problems so most of my clients really really really loved the csc in less than that perfect now i wanna i wanna actually get into this small little discussion about some of the common mistakes that companies make when they decide that they wanna go public peter i'll start with you on this

one i think you've touched on a few points already obviously having their audits in order is the most important one but i'm sure there's others you can add to as well yeah i think you know the audits done and worked on properly in advance times number one two i think is just getting your company ready to get diligence properly like having a good data room set up all your material contracts in

one place where whether you have an underwriter whether it's opposing counsel for the shell someone can look at that and review that all those are the two biggest ones corey is there any any hurdles any mistakes that you're able to talk about maybe from experience maybe not from experience yeah well i i don't know if there's been any mistakes i guess we'll find out but you know what i i think

one of the things that has been so important to us is to maintain a very tight capital structure and we've been able to do that that's very important to us as i've mentioned and i think the other thing is is you know the access to capital you know the old rule of thumb is if somebody wants to give you money in the you take it as a you know a small junior micro

stage company and capital's so important and we wouldn't be able to do be able to do what we're doing here right now without it so being able to structure everything properly we believe maybe we're i don't know if we're right or wrong but it's been very important for us to raise that capital well said corey thank you so we at this point i do want to remind the

audience members if you have any questions any comments anything you might be curious about feel free and jump into that chat column or in the question and answer box and and ask us these questions while we're here we're always available at a later date if you want to chat on a on a more sort of personal way but there are a couple of questions that have come in

from the audience and so i'll direct them over here let me just see what these questions are so this one comes to you corey so which what benefits musculo is seeking based on competitors suppliers located in current europe war zone i'm not sure if you want to take that one on on screen but you can always email them as well if you have something to input to that

one feel free yeah well so we're working with bayer in europe here right now i'm not sure if there's what what we're doing in ukraine probably nothing right now but you know we don't have a commercial product there we think our technology will fit in in the european union as a whole they're very very the regulatory area there is very strict in terms of the chemicals that

are being used a lot of them been banned so how are farmers going to grow crops we think our technology has a good fit there and you know with the unfortunate events happening in the european war zone it's bringing to the forefront food security and and how important it is and you know the ukraine is the is the bread basket of europe just like where i'm

from here saskatchewan is is as well so it's very important that you know this war comes to an end and they can start growing crops again to help feed the world so well said corey so that was the question from the audience if there are any more questions feel free and jump in we've got about 15 minutes remaining i don't really want to end this a little bit early but

you've had and you've had a chance to listen to three different viewpoints obviously myself from the standpoint of the canadian securities exchange which is a stock exchange here in canada you've heard from peter simeon he's a lawyer with gal links talking about you know going through the process and what companies look what companies need to have in order and then obviously from corey the viewpoint of a publicly listed

company that's already trading on the csc and has gone through that process so if there's any further questions i would encourage you all to you know send them our way we're here to answer them if not you know we encourage you to reach out to us at your own convenience by either email or phone call we've got all our contact details there feel free to reach out

anytime we're more than happy to answer any questions walk you through what that process of going public looks like and obviously i want to thank each and every one of you that has taken the time this morning afternoon to join us to find out a little bit more not only about the csc but also gallings as a law firm and muscular biologics as a publicly traded company under the symbol

mgro on the csc so maybe we'll give it a couple of minutes see if there's any questions if not what we'll do is i will just go to each of you peter and corey for a closing remark yeah happy to have you there well there's a question just popped up there is a question that popped up i guess you know don't be shy everybody watching feel free to jump in so

this question is how is the communication with retail investors and their activity in the csc corey do you want to take this one sure you know i i think we've probably done about four or five take stocks with the cse you know over the last two and a half years these are presentations to prospective investors you know i think they're probably about

seven or ten minute presentations they've been excellent so we're you know the cse has really allowed us to be able to communicate with our shareholders and they're you know it's it's it's been they've been excellent i will also mention too that you know there is just because you become a public company doesn't mean that you're going to get liquidity right away that's that needs to be earned you need to get

out there in front of retail investors institutional investors etc you got to go and tell your story tell about your company and and that helps helps create the liquidity in that which is which is so important that's one of the reasons why you are public you want to create that liquidity for your shareholders and you know the csc is definitely helps us do that great points corey and thanks for that

cse plug based on that i i will jump in here as well you know the csc is very proactive when it comes to making sure that the retail audience and the audience in general has a good knowledge of companies that are trading on the csc as well as other exchange various sectors so what i would suggest for the person that asked that question and to anybody watching take a look at csctv

it is our youtube channel and over the last little while we've been doing a lot of virtual content that we've been producing in-house like mining over canada series the investing in psychedelic series plant-based protein food series gaming and what we do there is we will try and bring together not only centers of influence within these various sectors but also public companies that are in this space

to talk about you know some of the some of the advantages the disadvantages the trends that they might be seeing so the csc is very proactive when it comes to getting out there and making sure that not only are we bringing companies to the market but then we're also going out there and telling their story to the general public as well so that that csctv this broadcast will also be available on

there for replay so take a look at that if you have any feedback for us let us know we have a podcast that we do we also put together a a virtual and print magazine that highlights various sectors of of companies listed on the csc so take a look at that our latest issue is based on plant-based foods it's it's quite an exciting issue

now peter there is another question that has come in and this one looks like it's for you are there things that gowlings looks for in taking on an international client and are there law firms in brazil gallons would work with yeah so i don't think we have sort of formal criteria we do have a broad range of clients we act for small startup companies all the way to

you know billion-dollar public companies so it is a broad range and we're not going to turn a client away because they're too small you know i've grown with a lot of my clients i love seeing small companies that are ideas started in people's you know basements turn into large public companies those are the funnest stories i like to work with companies that have interesting ideas and cool products

we don't have an office in brazil but we definitely have go-to law firms we've used in brazil and if people need a recommendation happy to give one sort of offline but depending on the size of the company what they're looking to do we have sort of three or four different kind of firms we use in brazil thank you for that peter now corey we've actually got another question that

popped in for you this is actually a really interesting one because it asks how important is the role of investor relations in getting your story out and can companies work with more than one ir company so for example having a ir company based out of canada where you are and then another one in brazil or or elsewhere yeah i mean as i mentioned before one of the most

important things for our company is to create liquidity for our stock so shareholders can buy and sell you know and then that is done through ir ir might be the the second most important thing after after operations and that because it does start with a an asset so you know we do a lot of work in that area we our goal is to get our

story out you know update existing shareholders and then try to tell our story to potential prospective new shareholders and that and if they want to invest great if not well you know look forward to getting more information from us in the future potentially so it's very important about using more than one ir company we don't really use an ir company we kind of have it in house but we use a

variety of different marketing groups and all that to get our story out you know in different regions you know in canada here in the us you know that's a large market that we're focusing in on obviously and internationally we've got a listing on the frankfurt exchange you know we we get our information translated into german so that it could be marketed there and and not so it's a very

important area thank you for that corey we've got a question that's come in what are your main requirements to get listed with the cse peter i'll jump into this one and then if you have anything to add to it feel free so listing on the csc obviously the most important thing is making sure you have your books and your audits in order but once you submit an

application there's an initial listing fee which is depends on the company it's roughly between let's say 15 000 canadian dollars to about 20 000 canadian dollars you then pay an annualized fee which is is roughly around between let's say 10 and 18 000 companies on the canadian securities exchange once they list they will pay a monthly listing fee which is around a thousand dollars depending on market

cap size and then you know obviously we don't charge any annual annual fees there's no transactional fees as you do it so basically those are the general costs to get listed on the cse which i've just answered but the main requirements would be to make sure you have your audits in order you submit an application or a prospectus and then making sure you've got two years working

capital enough to to enough to supplement your business for the next at least two years peter do you want something do you want to add to that yeah i guess the only other additional requirement i think is the the public board lots right you need 150 shareholders holding you know at least a boardwalk but it doesn't make sense for every company to go public it is costly

there's a lot of regulatory you know compliance you need to do you need to file quarterly annual financials there's a csv monthly report you do you know stock options rsu's like a lot of filings get made there's lots of compliance so you know you need to be i think of a big enough side or at least raise enough capital that you can pay for all that

and hire the right teams to take care of it yeah well said now we're very close to our cutoff time at 1pm so if there's no more questions what i would encourage is feel free and reach out at your own convenience to either of us either peter from gal ling's corey from musco if you want some feedback on what that process of listing on the csc out here

in canada looks like i do want to give a special shout out and a thank you sincerely to amanda munoz and her team leticia as well as clara who've helped us on behind the scenes to help put this together they are all with mz group which is based out of brazil and then on the csc's front i i do want to thank barrington miller who's helped out

with this from day one katrina who is with sparks to make sure that we've got all of the content that we get the right people in the room as well as james black who's helped with a lot of other stuff on the back end so i want to thank each and every one of you that you know is not on camera that has helped to make this presentation happen and of course

peter and corey for your your time this afternoon to to join myself and help educate and talk to the audience about a possible listing in canada again we do encourage you all to reach out to us at your own convenience our contact details are all available as well as the presentations that we shared today are available for you to download at your own convenience

any last remarks gents yeah i just want to thank you know and neil and thank the csc and mz for inviting to me to this this presentation has been great you know we give a very high level overview but the actual requirements are pretty technical so people have real questions let me know and we can walk through some of the more technical aspects thank you peter corey yeah neil

thanks for inviting muscular to present it's actually was a pretty good process to take a look back at over the last two and a half years and and to see remember why we actually went public and all that and all this and you know take a look at the past so it was great thank you perfect and again thanks for everyone to the that took the time to join us we

look forward to hopefully having you participate again in the next presentation that we do and maybe that one will be in person out in brazil next year thank you